Relationship between Sloan-Kettering virus expression and mammalian follicular development.

about

Relationship between Sloan-Kettering virus expression and mammalian follicular development.

Item

http://www.wikidata.org/entity/Q41528846

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Relationship between Sloan-Ket ...... malian follicular development.

@en

type

Item

label

Relationship between Sloan-Ket ...... malian follicular development.

@en

prefLabel

Relationship between Sloan-Ket ...... malian follicular development.

@en

P1476

Relationship between Sloan-Ket ...... malian follicular development.

@en

P2093

Changyong Choe

http://www.w3.org/2001/XMLSchema#string

Hwan-Hoo Seong

http://www.w3.org/2001/XMLSchema#string

Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Yeoung-Gyu Ko

http://www.w3.org/2001/XMLSchema#string

Young Moo Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation

Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling

Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

WAF1, a potential mediator of p53 tumor suppression

c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads

Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis

Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development

PAL31, a nuclear protein required for progression to the S phase

Proliferation related acidic leucine-rich protein PAL31 functions as a caspase-3 inhibitor

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0967199415000362

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280582682

http://www.w3.org/2001/XMLSchema#string

P698

26228242

http://www.w3.org/2001/XMLSchema#string